Myrtle S Potter
age ~67
from Atlanta, GA
- Also known as:
-
- Myrtle Stephens Potter
- Myrtle Potter Stephens
- Myrtle B Stephens
- Potter Myrtle Stephens
- Stephens Potter
Myrtle Potter Phones & Addresses
- Atlanta, GA
- San Jose, CA
- Reseda, CA
- San Francisco, CA
- Fort Lauderdale, FL
- Atherton, CA
- Woodside, CA
- Doylestown, PA
- Omaha, NE
- Houston, TX
- 7520 Chaparral Dr, Atlanta, GA 30350
Work
-
Company:Sumitovant biopharmaDec 2019
-
Position:Chief executive officer
Education
-
Degree:Bachelors, Bachelor of Arts
-
School / High School:University of Chicago1976 to 1980
Skills
Biotechnology • Strategy • Pharmaceutical Industry • Commercialization • Product Launch • Clinical Development • Lifesciences • Cross Functional Team Leadership • Leadership • Healthcare • Oncology • Strategic Planning • Managed Care • Life Sciences • Entrepreneurship • Business Strategy • Cardiology • Infectious Diseases • Medical Devices • Pharmaceutical Sales • Clinical Trials • Drug Development • Management • Marketing • Marketing Strategy • Fda • Start Ups • Sales Effectiveness • Personalized Medicine • Pharmacogenomics • Biopharmaceuticals • Neurology • Product Development • Health Care Reform • Positive Team Player • Team Leadership • Hospitals • Sales • Clinical Research • Lead A Team • Healthcare Information Technology • Biomarkers • Cancer • Corporate Communications
Industries
Biotechnology
Resumes
Chief Executive Officer
view sourceLocation:
Atlanta, GA
Industry:
Biotechnology
Work:
Sumitovant Biopharma
Chief Executive Officer
Roivant Sciences
Vant Operating Chair, Roivant Pharma
Myrtle Potter Media Aug 2009 - Dec 2014
President and Chief Executive Officer
Myrtle Potter & Company Aug 2009 - Dec 2014
President and Chief Executive Officer
Genentech 2000 - 2005
President - Commercial Operations
Chief Executive Officer
Roivant Sciences
Vant Operating Chair, Roivant Pharma
Myrtle Potter Media Aug 2009 - Dec 2014
President and Chief Executive Officer
Myrtle Potter & Company Aug 2009 - Dec 2014
President and Chief Executive Officer
Genentech 2000 - 2005
President - Commercial Operations
Education:
University of Chicago 1976 - 1980
Bachelors, Bachelor of Arts Mayfield High School 1973 - 1976
Bachelors, Bachelor of Arts Mayfield High School 1973 - 1976
Skills:
Biotechnology
Strategy
Pharmaceutical Industry
Commercialization
Product Launch
Clinical Development
Lifesciences
Cross Functional Team Leadership
Leadership
Healthcare
Oncology
Strategic Planning
Managed Care
Life Sciences
Entrepreneurship
Business Strategy
Cardiology
Infectious Diseases
Medical Devices
Pharmaceutical Sales
Clinical Trials
Drug Development
Management
Marketing
Marketing Strategy
Fda
Start Ups
Sales Effectiveness
Personalized Medicine
Pharmacogenomics
Biopharmaceuticals
Neurology
Product Development
Health Care Reform
Positive Team Player
Team Leadership
Hospitals
Sales
Clinical Research
Lead A Team
Healthcare Information Technology
Biomarkers
Cancer
Corporate Communications
Strategy
Pharmaceutical Industry
Commercialization
Product Launch
Clinical Development
Lifesciences
Cross Functional Team Leadership
Leadership
Healthcare
Oncology
Strategic Planning
Managed Care
Life Sciences
Entrepreneurship
Business Strategy
Cardiology
Infectious Diseases
Medical Devices
Pharmaceutical Sales
Clinical Trials
Drug Development
Management
Marketing
Marketing Strategy
Fda
Start Ups
Sales Effectiveness
Personalized Medicine
Pharmacogenomics
Biopharmaceuticals
Neurology
Product Development
Health Care Reform
Positive Team Player
Team Leadership
Hospitals
Sales
Clinical Research
Lead A Team
Healthcare Information Technology
Biomarkers
Cancer
Corporate Communications
Name / Title
Company / Classification
Phones & Addresses
CTO
Genentech Inc
Pharmaceutical Preparations
Pharmaceutical Preparations
Po Box 9030, South San Francisco, CA 94083
Manager
Chapman & Assoc LLC
Real Estate Development
Real Estate Development
410 S 1 St, San Jose, CA 95113
PO Box 880, San Jose, CA 95106
(408)2899998
PO Box 880, San Jose, CA 95106
(408)2899998
Tate 3939, LLC
Real Estate Holding · Nonclassifiable Establishments
Real Estate Holding · Nonclassifiable Establishments
1275 Lincoln Ave, San Jose, CA 95125
1346 The Alameda, San Jose, CA 95126
1346 The Alameda, San Jose, CA 95126
Silverton Abr, LLC
Real Estate Holding · Nonclassifiable Establishments
Real Estate Holding · Nonclassifiable Establishments
1346 The Alameda, San Jose, CA 95126
1275 Lincoln Ave, San Jose, CA 95125
1275 Lincoln Ave, San Jose, CA 95125
Marrambo, LLC
Real Estate Holding · Nonclassifiable Establishments
Real Estate Holding · Nonclassifiable Establishments
1275 Lincoln Ave, San Jose, CA 95125
1346 The Alameda, San Jose, CA 95126
1346 The Alameda, San Jose, CA 95126
Thanelor Fast III, LLC
Real Estate Holding
Real Estate Holding
1275 Lincoln Ave, San Jose, CA 95125
1346 The Alameda, San Jose, CA 95126
1346 The Alameda, San Jose, CA 95126
President
MYRTLE POTTER MEDIA, INC
1275 Lincoln Ave SUITE 7, San Jose, CA 95125
650 Page Ml Rd, Palo Alto, CA 94304
650 Page Ml Rd, Palo Alto, CA 94304
President
CHAPMAN BUILDERS, INC
2995 Woodside Rd STE 400, Redwood City, CA 94062
Us Patents
-
Methods And Systems For Growing And Retaining The Value Of Brand Drugs By Computer Predictive Model
view source -
US Patent:20190392539, Dec 26, 2019
-
Filed:Sep 6, 2019
-
Appl. No.:16/563471
-
Inventors:Myrtle S. POTTER - Dunwoody GA, US
-
International Classification:G06Q 50/22
G06Q 30/02 -
Abstract:The present invention is directed to a brand value growth and retention system for brand drugs commercialized by brand drug advertisers through a brand drug's lifecycle during patent exclusivity and after loss of exclusivity. The brand value growth and retention system iteratively analyzes combined computational models of consumer, healthcare provider retailer and payor segment data to produce brand drug promotional campaigns that are predictive with modifying parameters that transform the promotional campaigns over time. As a result, the brand drug promotional campaign generates an increased number of brand drug purchases while predicting the point where incremental promotional campaign investments produce a diminishing number of incremental brand drug purchases.
-
Methods And Systems For Growing And Retaining The Value Of Brand Drugs By Computer Predictive Model
view source -
US Patent:20180174257, Jun 21, 2018
-
Filed:Feb 20, 2018
-
Appl. No.:15/900456
-
Inventors:Myrtle S. POTTER - Dunwoody GA, US
-
International Classification:G06Q 50/22
G06Q 30/02 -
Abstract:The present invention is directed to a brand value growth and retention system for brand drugs commercialized by brand drug advertisers through a brand drug's lifecycle during patent exclusivity and after loss of exclusivity. The brand value growth and retention system iteratively analyzes combined computational models of consumer, healthcare provider retailer and payor segment data to produce brand drug promotional campaigns that are predictive with modifying parameters that transform the promotional campaigns over time. As a result, the brand drug promotional campaign generates an increased number of brand drug purchases while predicting the point where incremental promotional campaign investments produce a diminishing number of incremental brand drug purchases.
-
Methods And Systems For Growing And Retaining The Value Of Brand Drugs By Computer Predictive Model
view source -
US Patent:20140278507, Sep 18, 2014
-
Filed:Mar 14, 2014
-
Appl. No.:14/214636
-
Inventors:Myrtle S. POTTER - Dunwoody GA, US
-
International Classification:G06Q 50/22
G06Q 30/02 -
US Classification:705 2
-
Abstract:The present invention is directed to a brand value growth and retention system for brand drugs commercialized by brand drug advertisers through a brand drug's lifecycle during patent exclusivity and after loss of exclusivity. The brand value growth and retention system iteratively analyzes combined computational models of consumer, healthcare provider retailer and payor segment data to produce brand drug promotional campaigns that are predictive with modifying parameters that transform the promotional campaigns over time. As a result, the brand drug promotional campaign generates an increased number of brand drug purchases while predicting the point where incremental promotional campaign investments produce a diminishing number of incremental brand drug purchases.
News
Rite Aid reports 2.7% lift in Q1 sales; Wellness Stores now make up 29% of chain
view source- annual shareholder meeting, shareholders elected eight directors to hold office until the2015 Annual Meeting of Stockholders, including John Standley, Rite Aid chairman and CEO, and directors Joseph Anderson, Jr., BruceBodaken, David Jessick, Kevin Lofton, Myrtle Potter, Michael Regan and Marcy Syms. R
- Date: Jun 19, 2014
- Category: Business
- Source: Google
Classmates
Myrtle Potter
view sourceSchools:
Pantego High School Pantego NC 1955-1967
Community:
Welton Boomer, Jeannie Whitley, Sammy Allen, Brenda Oliver, Vivian Gibbs, Joyce Midgett, Gayle Bowen, Trudy Sterenberg, Betty Midgett, Glenn Askew
Youtube
Flickr
Plaxo
Myrtle Potter
view sourceSilicon Valley, California USA
Googleplus
Myrtle Potter
Work:
Genentech - President Commercial and COO (2000-2006)
Bristol-Myers Squibb - President, Cardiovascular/Metabolics Business (1996-2000)
Merck & Co. - Many Roles (1982-1996)
Procter & Gamble - Sales and Sales Training (1980-1982)
Bristol-Myers Squibb - President, Cardiovascular/Metabolics Business (1996-2000)
Merck & Co. - Many Roles (1982-1996)
Procter & Gamble - Sales and Sales Training (1980-1982)
Education:
University of Chicago - Bachelor of Arts Degree
About:
Myrtle Potter is one of America’s foremost healthcare leaders and innovators and a best-selling author. She has dedicated three decades of service and leadership to America’s most successful global h...
Myrtle Potter
Myrtle Potter Little Roc...
view sourceMyrtle Potter (Little Rock, AR)
Get Report for Myrtle S Potter from Atlanta, GA, age ~67